On September 4, 2018 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) reported that it will present at 2018 B. Riley FBR Healthcare Conference on Tuesday, September 4th and at the Maxim Rights Offering Conference on Thursday, September 6th, both of which are being held in New York City (Press release, Actinium Pharmaceuticals, SEP 4, 2018, View Source [SID1234529253]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company’s Chief Medical Officer, Mark Berger, M.D, will participate in a panel at the B. Riley FBR Healthcare Conference. Details of the panel are as follows:

Title:

Antibody-drug Conjugates are a Waning Technology

Date:

September 4, 2018

Time:

12:50 pm ET

Location:

New York Marriott East Side, Stuyvesant Room